Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
PCI Pharma Services Expands Global Manufacturing Network with $1B+ Investment in San Diego
PCI Pharma Services has announced an investment programme exceeding $1 billion across its US and European operations to strengthen sterile fillfinish and advanced drug delivery capabilities
Novartis Announces $23 Billion Investment to Expand API Manufacturing Facility in North Carolina
Novartis has announced plans to develop a new 56,200squarefoot manufacturing facility in Morrisville, North Carolina, as part of its wider $23 billion investment in USbased manufacturing and research
Cambrex Announces $150 Million Expansion across U.S. and European Facilities
Cambrex has revealed significant progress on its expansion initiatives across the United States and Europe These projects are designed to boost capacity for manufacturing complex drugs
Axplora Invests $60 Million to Expand High-Potency Drug Manufacturing Capacity
Axplora has announced a major expansion of its manufacturing and research capabilities in response to the growing demand for highly potent drugs The development will take place at its Farmabios site
CSL to Invest $1.5 Billion in Expansion of Illinois Plasma Therapy Facility
CSL has announced a $15 billion expansion of its manufacturing facility The expansion will significantly increase production of plasmaderived therapies and albumin
Johnson & Johnson Invests Over $1 Billion in New Cell Therapy Manufacturing Facility
Johnson Johnson has announced plans to invest more than $1 billion in a nextgeneration cell therapy manufacturing facility in Montgomery County, Pennsylvania The new site will expand the companys manufacturing capacity
AbbVie Announces $380 Million Expansion of API Manufacturing in North Chicago
AbbVie has revealed plans to invest $380 million to expand its active pharmaceutical ingredient API production capabilities at its North Chicago campus The initiative involves constructing
PharmaEssentia Invests $46M to Expand U.S. Manufacturing Footprint for BESREMi®
PharmaEssentia Corporation has announced plans to establish a new wholly owned manufacturing subsidiary in Puerto Rico The US$46 million investment aims to expand the production of BESREMi
Novartis Expands R&D Capacity with $23B San Diego Investment
Novartis has begun construction on a new global Biomedical Research centre in San Diego, California, as part of a USD 23 billion investment in US research and development and advanced manufacturing
Vetter Pharma Plans State-of-the-Art €480M Production Facility in Germany
Vetter Pharma, a leading global pharmaceutical service provider specialising in injectable drugs, has announced plans to build a new stateoftheart production facility in Saarlouis, Saarland, southwest Germany
